- Learn about the program: The BioLINCC Handbook (PDF - 2.4 MB)
- View the NHLBI Biorepository Guide to Building Biospecimen Collections
- Read about the establishment and development of BioLINCC
- Register a BioLINCC Account, enabling you to request resources
- View the NHLBI Biorepository video: NHLBI Biospecimen and Data Repository Program: Advancing Medical Research
- Learn about the results of the first 6 years of BioLINCC
Search for Study Datasets and/or Biospecimens
Featured News - 4 Items
New information regarding secondary data and/or biospecimen analysis funding opportunities from NHLBI, NIDDK, and FDA has been added to the funding opportunities page. These NIH Exploratory (R21) grant funding opportunities may be applicable to research using BioLINCC resources. Additionally included is an NHLBI released Notice of Special Interest (NOSI) on Data Science R01 applications. Please see the funding opportunities page, which includes links to the NIH grant announcements, for more information.
In collaboration with the NHLBI Biorepository and the Trans-NIH AgingResearchBiobank Steering Committee, NHLBI has developed COVID-19 Biorepository FAQs to serve as a resource/reference for the scientific community. This includes descriptions of enhanced procedures employed by the Biorepository to ensure staff safety and to mitigate the potential of airborne exposure to COVID-19 virus particles, as well as references to CDC shipping guidelines for suspected and confirmed SARS-CoV-2 patient specimens, cultures, or isolates. Click here to access this FAQ document.
The NHLBI Cure Sickle Cell Initiative has established a web-based publicly available Metadata Catalog of curated data elements and study documentation from past and current studies of sickle cell disease populations. The catalog has over 10,000 data variables from 16 studies organized into searchable categories. Tools to help investigators find data elements and determine the availability of common data for cross-study analysis are provided. Visit the catalog at https://curesicklecell.rti.org/.
DNA biospecimens from the Hydroxyurea to Prevent Organ Damage in Children with Sickle Cell Anemia (BABY HUG) Phase III Clinical Trial and Follow-Up Observational Studies I and II are now available for request.
Data have been updated for the Multi-Ethnic Study of Atherosclerosis (MESA). This update includes the addition of Exam 5 cognitive abilities screening instrument variables and Exam 5 co…
DNA biospecimens from the Hydroxyurea to Prevent Organ Damage in Children with Sickle Cell Anemia (BABY HUG) Phase III Clinical Trial and Follow-Up Observational Studies I and II are now…
A new study, Blood and Marrow Transplant Clinical Trials Network (BMT CNT) A Phase II/III Randomized, Multicenter Trial Comparing Sirolimus Plus Prednisone and Sirolimus/Calcineurin Inhi…